Business · 08/07/2014
FDA Classifies Transcranial Magnetic Stimulator for Headache into Class II with Special Controls
The FDA is classifying the transcranial magnetic stimulator for headache into Class II with special controls to ensure the device's safety and effectiveness, following a classification order that outlines the applicable controls. This move aims to provide a reasonable assurance of the device's performance.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →